Abstract:In an ongoing investigation of 20-sulfonylamidine derivatives (9, YQL-9a) of camptothecin (1) as potential anticancer agents directly and selectively inhibiting topoisomerase (Topo) I, the sulfonylamidine pharmacophore was held constant, and a camptothecin derivatives with various substitution patterns were synthesized. The new compounds were evaluated for antiproliferative activity against three human tumor cell lines, A-549, KB, and multidrug resistant (MDR) KB subline (KBvin). Several analogs showed comparable or superior antiproliferative activity compared to the clinically prescribed 1 and irinotecan (3). Significantly, the 20-sulfonylamidine derivatives exhibited comparable cytotoxicity against KBvin, while 1 and 3 were less active against this cell line. Among them, compound 15c displayed much better cytotoxic activity than the controls 1, 3, and 9. Novel key structural features related to the antiproliferative activities were identified by structure-activity relationship (SAR) analysis. In a molecular docking model, compounds 9 and 15c interacted with Topo I-DNA through a different binding mode from 1 and 3. The sulfonylamidine side chains of 9 and 15c could likely form direct hydrogen bonds with Topo I, while hydrophobic interaction with Topo I and π-π stacking with double strand DNA were also confirmed as binding driving forces. The results from docking models were consistent with the SAR conclusions. The introduction of bulky substituents at the 20-position contributed to the altered binding mode of the compound by allowing them to form new interactions with Topo I residues. The information obtained in this study will be helpful for the design of new derivatives of 1 with most promising anticancer activity.

Total Synthesis of 7-Ethyl-10-hydroxycamptothecin (SN38) and Its Application to the Development of C18-functionalized Camptothecin Derivatives.

Synthetic Studies on Camptothecins. Part 3

Total synthesis of camptothecin and SN-38.

Design and One-Pot Synthesis of New 7-Acyl Camptothecin Derivatives As Potent Cytotoxic Agents

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs

Expeditious Total Syntheses of Camptothecin and 10-Hydroxycamptothecin

First Synthesis of Novel Spin-Labeled Derivatives of Camptothecin As Potential Antineoplastic Agents

Synthetic Studies On Camptothecins Part 1 An Improved Asymmetric Total Synthesis Of (20s)-Camptothecin

Organo-cation catalyzed enantioselective α-hydroxylation of pyridinone-fused lactones: asymmetric synthesis of SN-38 and irinotecan

Synthetic Studies on Camptothecins. Part 1

Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity

Design, Synthesis, Cytotoxic Activity and Molecular Docking Studies of New 20(S)-Sulfonylamidine Camptothecin Derivatives

Synthesis and Antitumor Activity of 9-Methyl-10-hydroxycamptothecin

Design, synthesis and cytotoxic activity of sulfonylated derivatives of camptothecin

A Novel and Enantioselective Total Synthesis of (20S)-Camptothecin Via A Sharpless Asymmetric Dihydroxylation Strategy

Design, Synthesis and Biological Evaluation of Novel Homocamptothecin Analogues As Potent Antitumor Agents.

An Improved Synthesis of (20S)-Camptothecin and Its Analogue Via an Asymmetric Α-Hydroxylation with a Chiral Organocatalyst

ChemInform Abstract: Synthesis and Biological Activities of Fluorinated 10‐hydroxycamptothecin and SN38.

Synthesis and Antitumor Activity of the Hexacyclic Camptothecin Derivatives.

Synthesis of novel 10,11-methylenedioxy-camptothecin glycoside derivatives and investigation of their anti-tumor effects in vivo